2022

1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

   Clinical cancer research : an official journal of the American Association for Cancer Research

2. Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting

   Cancers, Vol. 14, Núm. 18